Mitochondrial Testing Services for Drug Discovery and Toxicology Screening
The Issue
Mitochondrial dysfunction contributes to many diseases including Parkinson's and Alzheimer's disease, diabetes, cancer, and osteoarthritis. Finding drugs to improve mitochondrial functioning is critical to treatment of these diseases. In addition, the evidence for mitochondrial toxicity of
many drugs compels the testing of potential drug compounds for their effects on mitochondrial function.
The Problem
Most companies have very few researchers experienced in mitochondrial biology, and these people are often spread across several research sites.
The Solution
Contract with MitoSciences. Our MitoProfile® technology provides HTS of compounds, and is a seamless technology that provides equivalent data from initial compound evaluations to phase III clinical trials.
The Process: The MitoSciences Service >
|
Consultation Request >
|
CART
